NTRK1 and neoplasm: In the NTRK-fused CNS tumours in our patients, pan-TRK IHC using clone A7H6R and clone EPR17341 revealed diffuse cytoplasmic positivity with sparing of nuclei in nearly 100% of the tumour cells across all cases.